UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

FSU researcher: Family of rodents may explain how some groups of animals become so diverse

How did a single species of rodent invade South America and then quickly branch off…

UCF Researcher Working to Develop Device to Rapidly Detect Heart Attacks

While tests for heart attacks currently exist, they are slow and require specially trained personnel.…

FIU: Saturn’s largest moon may hold key to cleaner engines

FIU chemist Alexander Mebel and a team of international researchers have been studying Saturn’s largest…